BioPharma

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines

Daewoong Pharmaceutical (CEO Sengho Jeon & Changjae Lee) recently announced that it has submitted the New Drug Application (NDA) for a n...

 March 29, 2022 | News

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...

 March 28, 2022 | News

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...

 March 25, 2022 | News

RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics

Under the agreement, both companies will collaborate to develop next-generation mRNA-based antibody therapeutics by utilizing the proprietary mRNA platform...

 March 22, 2022 | News

BioVaxys Announces Bioproduction of BVX-1021

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), today announced that it has entered into an agreem...

 March 21, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

 March 18, 2022 | News

NuclixBio Announces a Collaborative Research Agreement with PharmAbcine

Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA™' to ...

 March 15, 2022 | News

Everest Medicines to further enhance its international commercial footprint

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...

 March 14, 2022 | News

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...

 March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

 March 03, 2022 | News

BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development

German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...

 March 01, 2022 | News

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing...

 February 28, 2022 | News

HitGen , MTPC to discover novel hit compounds for multiple drug targets

During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...

 February 25, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

 February 18, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close